HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CRMBM solution

also contains KCl, CaCl2, NaOH, KH2PO4, MgCl2, lactobionic acid, glutamate, mannitol & adenosine; pH 7.4

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Allopurinol: 3719
        CRMBM solution: 5
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Glutathione: 14524
      - CRMBM solution: 5
Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Trisaccharides: 123
      - Raffinose: 146
        CRMBM solution: 5

Experts

1.	Bernard, M: 4 articles (12/2014 - 01/2003)
2.	Cozzone, P J: 4 articles (12/2014 - 01/2003)
3.	Desrois, M: 4 articles (12/2014 - 01/2003)
4.	Caus, T: 3 articles (12/2014 - 11/2004)
5.	Lan, C: 3 articles (12/2014 - 01/2003)
6.	Dalmasso, C: 2 articles (12/2014 - 12/2009)
7.	Fourré, D: 1 article (12/2014)
8.	Piccardo, A: 1 article (12/2014)
9.	Zogheib, E: 1 article (12/2014)
10.	Maixent, J M: 1 article (11/2004)

Related Diseases

1.	Ischemia 12/20/2009 - "In conclusion, we show here that CRMBM solution did not increase NO production during ischemia but induced an enhanced synthesis of NO during reperfusion which may be related to restoration of endothelial NOS expression and/or induction of inducible NOS expression." 01/01/2003 - "Isolated isovolumic rat hearts (n = 23) were submitted to 8 h of hypothermic ischemia after cardioplegic arrest with the Centre de Résonance Magnétique Biologique et Médicale (CRMBM) solution with or without L-arginine (Arg and No Arg groups respectively). " 11/01/2004 - "Na,K-ATPase activity was not altered after 12 hr of ischemia and 1 hr reflow when the CRMBM solution was used for preservation (55 +/- 2 micromolPi/mg prot/hr) compared to control (53 +/- 2 micromol Pi/mg prot/hr) while it was significantly altered with UW solution (44 +/- 2 micromol Pi/mg prot/hr, p < 0.05 vs control and CRMBM). " 01/01/2003 - "Addition of L-arginine to the CRMBM solution limited aspartate depletion and decreased lysine level at the end of ischemia. "
2.	Exsanguination 12/01/2014 - "In DCD, hearts were excised 20 minutes after exsanguination and asphyxia, stored in the Centre de Résonance Magnétique Biologique et Médicale (CRMBM) solution for 2 hours, and then were reperfused. "
3.	Myocardial Stunning (Stunned Myocardium) 02/01/2003 - "During early reperfusion, the limited myocardial stunning observed with CRMBM solution containing L-arginine does not relate to energy metabolism but to better preservation of the NO pathway."
4.	Asphyxia (Suffocation) 12/01/2014 - "In DCD, hearts were excised 20 minutes after exsanguination and asphyxia, stored in the Centre de Résonance Magnétique Biologique et Médicale (CRMBM) solution for 2 hours, and then were reperfused. "

Related Drugs and Biologics

1.	Arginine (L-Arginine)
2.	Lysine (L-Lysine)
3.	Aspartic Acid (Aspartate)
4.	Adenosine Triphosphatases (ATPase)
5.	University of Wisconsin-lactobionate solution
6.	dicarboxydine (DCD)